Mortality risk assessment process in patients with a systemic inflammatory response syndrome (SIRS) or sepsis

摘要

The invention relates to a method for assessing mortality risk in patients presenting with a systemic inflammatory response (sirs) or septic syndromes comprising measuring scd127 expression in a biological sample.